How severe is CVE-2022-48221?

CVE-2022-48221 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with high attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2022-48221 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (40th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2022-48221?

CVE-2022-48221 affects Gbgplc Acuant Acufill Sdk. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2022-48221?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2022-48221 published?

CVE-2022-48221 was published on 2023-04-04 and last updated on 2026-06-17.

CVE-2022-48221

CVE-2022-48221 is a high-severity vulnerability in Gbgplc Acuant Acufill Sdk with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-362.

Key facts

Severity: High (CVSS 3.x base score 7.5)
EPSS exploit prediction: 1% (40th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-362
Affected product: Gbgplc Acuant Acufill Sdk
Published: 2023-04-04
Last modified: 2026-06-17

Description

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. Multiple MSI's get executed out of a standard-user writable directory. Through a race condition and OpLock manipulation, these files can be overwritten by a standard user. They then get executed by the elevated installer. This gives a standard user full SYSTEM code execution (elevation of privileges).

Frequently asked questions

What is CVE-2022-48221?: An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. Multiple MSI's get executed out of a standard-user writable directory. Through a race condition and OpLock manipulation, these files can be overwritten by a standard user. They then get executed by the elevated installer. This gives a standard user full SYSTEM code execution (elevation of privileges).
How severe is CVE-2022-48221?: CVE-2022-48221 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with high attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-48221 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (40th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-48221?: CVE-2022-48221 affects Gbgplc Acuant Acufill Sdk. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-48221?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2022-48221 published?: CVE-2022-48221 was published on 2023-04-04 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:gbgplc:acuant_acufill_sdk:*:*:*:*:*:*:*:*

More vulnerabilities in Gbgplc Acuant Acufill Sdk

CVE-2022-48222 — High (CVSS 7.8): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During SDK installation, certutil.exe is called by…
CVE-2022-48226 — High (CVSS 7.8): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of…
CVE-2022-48224 — High (CVSS 7.3): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is installed with insecure permissions (full write…
CVE-2022-48225 — High (CVSS 7.3): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is used to install drivers from several different…
CVE-2022-48223 — Medium (CVSS 6.7): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During SDK repair, certutil.exe is called by the…

All CVEs affecting Gbgplc Acuant Acufill Sdk →

Other CWE-362 (Race Condition) vulnerabilities

CVE-2022-27626 — Critical (CVSS 10.0): A vulnerability regarding concurrent execution using shared resource with improper synchronization ('Race Condition')…
CVE-2015-8556 — Critical (CVSS 10.0): Local privilege escalation vulnerability in the Gentoo QEMU package before 2.5.0-r1.
CVE-2014-0703 — Critical (CVSS 10.0): Cisco Wireless LAN Controller (WLC) devices 7.4 before 7.4.110.0 distribute Aironet IOS software with a race condition…
CVE-2010-1228 — Critical (CVSS 10.0): Multiple race conditions in the sandbox infrastructure in Google Chrome before 4.1.249.1036 have unspecified impact and…
CVE-2008-6598 — Critical (CVSS 10.0): Multiple race conditions in WANPIPE before 3.3.6 have unknown impact and attack vectors related to "bri restart logic."
CVE-2026-46137 — Critical (CVSS 9.8): In the Linux kernel, the following vulnerability has been resolved: mptcp: pm: ADD_ADDR rtx: fix potential…

Browse all CWE-362 (Race Condition) vulnerabilities →